BioXcel Therapeutics, Inc. - BTAI
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 30, 2026 | SCHEDULE 13G/A | Qatar Investment Authority | 0.6% | 156,066 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 8.4% | 1,833,717 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 8.4% | 1,835,192 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 8.4% | 1,835,192 | View |
| Feb 09, 2026 | SCHEDULE 13G/A | Israel A. Englander | 8.4% | 1,835,192 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.